Peter K.S. Siegl, Ph.D. Siegl Pharma Consulting LLC [email protected] SAFETY PHARMACOLOGY: Opportunities and Expectations 8 th Annual Safety Pharmacology.
Randomization & Blinding Dr. Aparna Walanj Clinical Research Head Ethika Clinical Research Center.
Biometrics India, Pfizer Global R & D
29/11/2007KLE University, Belgaum - 10 1 CURRENT PHARMACOLOGY & TOXICOLOGY GUIDLINES FOR PHARMACEUTICAL INDUSTRY Dr. Basavaraj K. Nanjwade M.Pharm., Ph.D.
Randomization & Blinding
Regulatory Perspective
Interpreting of Patient-Reported Outcomes
Marc Bailie DVM, PhD Director In Vivo Facility Michigan State University,
The Anti-Aging Insider Newspaper
ORIENTATION FOR NEW RESEARCH STUDY STAFF Clinical Trial Charge Capture and Research Invoicing October 2012.
DIVISION OF LIBRARY SERVICES | OFFICE OF RESEARCH SERVICES | NATIONAL INSTITUTES OF HEALTH Telling the Research Story: A Role for Librarians in Analyzing.
The Whats, Whys and Hows of Hispanics & Latinos’ involvement in Clinical Research Sara Tylosky MMG CONFIDENTIAL.